Protocol Activity | Screen (Week -4-0) | Base-line/ Randomization | Titration (Week 1-3) | Treatment Period 1 (Week 4- 11) | Tapering Week 12-13 | Washout Week 14-15 | Titration (Week 16-18) | Treatment Period 2 (Week 19- 26) | Tapering Week 27-28 | Follow-up Week 33 | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinic Visita | V1 | V2 | T1-2 | V3 | T3-T5 | V4 | T6 | V5 | T7-T8 | V6 | T9-T11 | V7 | T12 | V8 |
Informed Consent | X | |||||||||||||
Inclusion/Exclusion criteria | X | |||||||||||||
Randomizationb | X | |||||||||||||
Medical History | X | |||||||||||||
Demography | X | |||||||||||||
Physical Examination (Full) | X | |||||||||||||
Physical Examination (Brief) | X | X | X | X | X | X | ||||||||
Weight and Height | X | |||||||||||||
Safety Laboratory Testsc | X | X | X | X | X | X | ||||||||
FSHd | X | |||||||||||||
HbA1c blood teste | X | |||||||||||||
12-lead ECG | X | X | X | X | X | X | ||||||||
BP (supine and standing) and PR | X | X | X | X | X | X | ||||||||
Daily Pain Diary (PI-NRS)f | X | X | ||||||||||||
Daily Sleep Interference Scale (DSIS)g | X | X | ||||||||||||
Neuropathic Pain Scale (NPS) | X | X | X | X | X | X | X | X | X | X | X | X | X | |
SFN-SIQ Questionnaire | X | X | X | X | X | X | X | X | X | X | X | X | X | |
Patient Global Impression of Change | X | X | X | X | X | X | X | X | X | X | X | X | ||
SF-36 | X | X | X | X | ||||||||||
Adverse Event Monitoringh | X | X | ||||||||||||
Concomitant Medicationh | X | X | ||||||||||||
Dispense Study Medicationi | X | X | X | X | X | X | ||||||||
Retrieve Study Medication dispensed at previous study visit | X | X | X | X | X | X | ||||||||
Dispense Rescue Medication | X | X | X | X | X | X | ||||||||
Retrieve Rescue Medication dispensed at previous study visit | X | X | X | X | X | X | ||||||||
Dispense and instruct on Daily Pain Diaries | X | |||||||||||||
Retrieve Daily Pain Diary | X | X | X | X | X | X | X | X | ||||||
Study medication compliance check | X | X | X | X | X | X |